New User:

-or-
Username:
Password:
Forgot your password?

Stock Market & Financial Investment News

News Breaks
January 6, 2014
06:01 EDTACORAcorda Therapeutics downgraded to Neutral from Buy at Citigroup
Citigroup downgraded Acorda Therapeutics citing a lack of near-term catalysts and lowered its price target for shares to $33 from $37.
News For ACOR From The Last 14 Days
Sign up for a free trial to see the rest of the stories you've been missing.
October 30, 2014
06:42 EDTACORAcorda Therapeutics: More than 60% of new AMPYRA patients enroll in First Step
Subscribe for More Information
06:42 EDTACORAcorda Therapeutics backs FY14 R&D expense $60M-$70M
Subscribe for More Information
06:41 EDTACORAcorda Therapeutics reports Q3 Ampyra revenue $96.4M
Subscribe for More Information
06:14 EDTACORAcorda Therapeutics reports Q3 non-GAAP EPS 65c, may not be comparable to 5c
Subscribe for More Information
October 29, 2014
07:09 EDTACORAlkermes sees FY14 free cash flow $20M
Subscribe for More Information

Sign up for a free trial to see the rest of the stories you've been missing.

I agree to the theflyonthewall.com disclaimer & terms of use